Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2013 1
2014 1
2015 2
2016 5
2017 3
2018 1
2019 2
2022 1
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence.
Shien T, Tanaka T, Tanabe M, Okumura Y, Masuda N, Yoshida A, Arima N, Komoike Y, Tanaka S, Iwase T, Taguchi T, Nakatsukasa K, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Shien T, et al. Oncol Lett. 2017 Mar;13(3):1071-1077. doi: 10.3892/ol.2016.5538. Epub 2016 Dec 27. Oncol Lett. 2017. PMID: 28454215 Free PMC article.
The expression and clinical significance of ALDH1 in ipsilateral breast tumor recurrence (IBTR) has yet to be investigated. In the present study, the expression profile of ALDH1 and its correlation with prognosis in IBTR tissues was examined. Patients with IBTR from eight …
The expression and clinical significance of ALDH1 in ipsilateral breast tumor recurrence (IBTR) has yet to be investigated. In the present …
Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in Japan.
Yamakado R, Ishitobi M, Kondo N, Yamauchi C, Sasada S, Nogi H, Saiga M, Ogiya A, Narui K, Seki H, Nagura N, Shimo A, Sakurai T, Niikura N, Mori H, Shien T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Yamakado R, et al. Breast Cancer. 2023 Mar;30(2):302-308. doi: 10.1007/s12282-022-01421-6. Epub 2022 Dec 17. Breast Cancer. 2023. PMID: 36527601 Free PMC article.
Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.
Saeki S, Iwatani T, Kitano A, Sakurai N, Tanabe Y, Yamauchi C, Igarashi A, Kajimoto Y, Kuba S, Hara F, Sagara Y, Ohno S; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Saeki S, et al. Breast Cancer. 2023 Sep;30(5):820-830. doi: 10.1007/s12282-023-01476-z. Epub 2023 Jun 13. Breast Cancer. 2023. PMID: 37310584 Free PMC article.
The situation regarding FT in Japan, however, has not been well explored. This study examined FT in patients with breast cancer in Japan and presented an overview of the group study's overall findings. ...The analysis also showed that physicians with a better …
The situation regarding FT in Japan, however, has not been well explored. This study examined FT in patients with breast cancer in Ja …
Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction: A Retrospective Multi-institutional Study of 4153 Cases.
Ogiya A, Nagura N, Shimo A, Nogi H, Narui K, Seki H, Mori H, Sasada S, Ishitobi M, Kondo N, Yamauchi C, Akazawa K, Shien T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Ogiya A, et al. Ann Surg Oncol. 2023 Oct;30(11):6532-6540. doi: 10.1245/s10434-023-13832-6. Epub 2023 Jul 5. Ann Surg Oncol. 2023. PMID: 37405666
BACKGROUND: The number of breast cancer patients in Japan undergoing immediate breast reconstruction (IBR) has increased and the postoperative follow-up period has been extended. This study was conducted to clarify the clinical aspects of, and factors associated with, loca …
BACKGROUND: The number of breast cancer patients in Japan undergoing immediate breast reconstruction (IBR) has increased and the postoperati …
Local recurrence risk after previous salvage mastectomy.
Tanabe M, Iwase T, Okumura Y, Yoshida A, Masuda N, Nakatsukasa K, Shien T, Tanaka S, Komoike Y, Taguchi T, Arima N, Nishimura R, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Tanabe M, et al. Eur J Surg Oncol. 2016 Jul;42(7):980-5. doi: 10.1016/j.ejso.2016.03.008. Epub 2016 Mar 26. Eur J Surg Oncol. 2016. PMID: 27055945
However, it is not rare for patients with IBTR who have received salvage mastectomy to develop local recurrence. In this study, we examined the risk factors of local recurrence after salvage mastectomy for IBTR. ...CONCLUSION: The lymph node status of the primary tumor mig …
However, it is not rare for patients with IBTR who have received salvage mastectomy to develop local recurrence. In this study, we ex …
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy.
Nogi H, Ogiya A, Ishitobi M, Yamauchi C, Mori H, Shimo A, Narui K, Nagura N, Seki H, Sasada S, Sakurai T, Shien T; Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society. Nogi H, et al. Breast Cancer. 2024 May;31(3):507-518. doi: 10.1007/s12282-024-01570-w. Epub 2024 Apr 4. Breast Cancer. 2024. PMID: 38573438 Free PMC article.
We assessed the impact of NAC on surgical and oncological outcomes of patients undergoing IBR. METHODS: This was a retrospective multicenter study of 4726 breast cancer cases undergoing IBR. The rate of postoperative complications and survival data were compared between IB …
We assessed the impact of NAC on surgical and oncological outcomes of patients undergoing IBR. METHODS: This was a retrospective multicenter …
Impact of radiation therapy for breast cancer with involved surgical margin after immediate breast reconstruction: A multi-institutional observational study.
Sasada S, Nagura N, Shimo A, Ogiya A, Saiga M, Seki H, Mori H, Kondo N, Ishitobi M, Narui K, Nogi H, Yamauchi C, Sakurai T, Shien T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Sasada S, et al. Eur J Surg Oncol. 2024 Jun;50(6):108360. doi: 10.1016/j.ejso.2024.108360. Epub 2024 Apr 22. Eur J Surg Oncol. 2024. PMID: 38669780
Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
Nakatsukasa K, Koyama H, Ouchi Y, Ono H, Sakaguchi K, Matsuda T, Kato M, Ishikawa T, Yamada K, Yoshimura M, Koizumi K, Sakurai T, Shigematsu H, Takahashi S, Taira S, Suzuki M, Narui K, Niikura N, Hasegawa Y, Miura D, Konishi E, Taguchi T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Nakatsukasa K, et al. Breast Cancer. 2019 Jan;26(1):106-112. doi: 10.1007/s12282-018-0896-y. Epub 2018 Jul 27. Breast Cancer. 2019. PMID: 30054855 Clinical Trial.
Previously, we reported the 12-month effect of denosumab in Japanese patients for the first time; the primary endpoint was the change in the percentage of bone mineral density (BMD) of the lumbar spine from baseline to 12 months. METHODS: This secondary follow-up study pro …
Previously, we reported the 12-month effect of denosumab in Japanese patients for the first time; the primary endpoint was the change in the …
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence.
Okumura Y, Nishimura R, Nakatsukasa K, Yoshida A, Masuda N, Tanabe M, Shien T, Tanaka S, Arima N, Komoike Y, Taguchi T, Iwase T, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Okumura Y, et al. Eur J Surg Oncol. 2015 Apr;41(4):548-52. doi: 10.1016/j.ejso.2015.01.030. Epub 2015 Feb 7. Eur J Surg Oncol. 2015. PMID: 25682910
PATIENTS AND METHODS: A total of 117 patients with IBTR without distant metastases were enrolled in this study. All patients were examined for estrogen receptor (ER), HER2, and Ki-67 in both the primary tumors and paired IBTR. ...
PATIENTS AND METHODS: A total of 117 patients with IBTR without distant metastases were enrolled in this study. All patients were exa …
Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR.
Ishitobi M, Okumura Y, Nishimura R, Nakatsukasa K, Tanabe M, Yoshida A, Masuda N, Shien T, Tanaka S, Komoike Y, Arima N, Taguchi T, Inaji H; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Ishitobi M, et al. Breast Cancer. 2014 Nov;21(6):754-60. doi: 10.1007/s12282-013-0454-6. Epub 2013 Mar 13. Breast Cancer. 2014. PMID: 23483442 Clinical Trial.
19 results